HIMS & HERS HEALTH INC (HIMS) Fundamental Analysis & Valuation

NYSE:HIMS • US4330001060

Current stock price

26.33 USD
-1.58 (-5.66%)
At close:
26.4 USD
+0.07 (+0.27%)
Pre-Market:

This HIMS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. HIMS Profitability Analysis

1.1 Basic Checks

  • In the past year HIMS was profitable.
  • HIMS had a positive operating cash flow in the past year.
  • In multiple years HIMS reported negative net income over the last 5 years.
  • In multiple years HIMS reported negative operating cash flow during the last 5 years.
HIMS Yearly Net Income VS EBIT VS OCF VS FCFHIMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

1.2 Ratios

  • The Return On Assets of HIMS (5.96%) is better than 80.00% of its industry peers.
  • HIMS's Return On Equity of 23.73% is amongst the best of the industry. HIMS outperforms 92.00% of its industry peers.
  • The Return On Invested Capital of HIMS (5.49%) is better than 62.00% of its industry peers.
Industry RankSector Rank
ROA 5.96%
ROE 23.73%
ROIC 5.49%
ROA(3y)6.14%
ROA(5y)-5.02%
ROE(3y)14.44%
ROE(5y)-1.98%
ROIC(3y)N/A
ROIC(5y)N/A
HIMS Yearly ROA, ROE, ROICHIMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20 -30

1.3 Margins

  • With a decent Profit Margin value of 5.47%, HIMS is doing good in the industry, outperforming 80.00% of the companies in the same industry.
  • The Operating Margin of HIMS (5.18%) is better than 63.00% of its industry peers.
  • Looking at the Gross Margin, with a value of 73.83%, HIMS belongs to the top of the industry, outperforming 91.00% of the companies in the same industry.
  • HIMS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.18%
PM (TTM) 5.47%
GM 73.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.63%
GM growth 5YN/A
HIMS Yearly Profit, Operating, Gross MarginsHIMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. HIMS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HIMS is destroying value.
  • HIMS has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for HIMS has been increased compared to 5 years ago.
  • HIMS has a worse debt/assets ratio than last year.
HIMS Yearly Shares OutstandingHIMS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
HIMS Yearly Total Debt VS Total AssetsHIMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • HIMS has an Altman-Z score of 3.64. This indicates that HIMS is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.64, HIMS is in the better half of the industry, outperforming 73.00% of the companies in the same industry.
  • HIMS has a debt to FCF ratio of 16.94. This is a negative value and a sign of low solvency as HIMS would need 16.94 years to pay back of all of its debts.
  • HIMS has a Debt to FCF ratio of 16.94. This is in the lower half of the industry: HIMS underperforms 64.00% of its industry peers.
  • HIMS has a Debt/Equity ratio of 1.80. This is a high value indicating a heavy dependency on external financing.
  • HIMS has a worse Debt to Equity ratio (1.80) than 71.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 16.94
Altman-Z 3.64
ROIC/WACC0.62
WACC8.86%
HIMS Yearly LT Debt VS Equity VS FCFHIMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 1.90 indicates that HIMS should not have too much problems paying its short term obligations.
  • With a decent Current ratio value of 1.90, HIMS is doing good in the industry, outperforming 79.00% of the companies in the same industry.
  • HIMS has a Quick Ratio of 1.70. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.70, HIMS is in the better half of the industry, outperforming 72.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 1.7
HIMS Yearly Current Assets VS Current LiabilitesHIMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. HIMS Growth Analysis

3.1 Past

  • HIMS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.56%.
  • Looking at the last year, HIMS shows a very strong growth in Revenue. The Revenue has grown by 59.00%.
  • Measured over the past years, HIMS shows a very strong growth in Revenue. The Revenue has been growing by 64.55% on average per year.
EPS 1Y (TTM)-5.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.27%
Revenue 1Y (TTM)59%
Revenue growth 3Y64.55%
Revenue growth 5YN/A
Sales Q2Q%28.41%

3.2 Future

  • Based on estimates for the next years, HIMS will show a very strong growth in Earnings Per Share. The EPS will grow by 50.73% on average per year.
  • HIMS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.74% yearly.
EPS Next Y14%
EPS Next 2Y11.95%
EPS Next 3Y33.46%
EPS Next 5Y50.73%
Revenue Next Year17.4%
Revenue Next 2Y18.31%
Revenue Next 3Y17.66%
Revenue Next 5Y13.74%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
HIMS Yearly Revenue VS EstimatesHIMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B 4B 5B
HIMS Yearly EPS VS EstimatesHIMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

2

4. HIMS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 51.63, which means the current valuation is very expensive for HIMS.
  • HIMS's Price/Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 26.54, HIMS is valued quite expensively.
  • A Price/Forward Earnings ratio of 45.29 indicates a quite expensive valuation of HIMS.
  • The rest of the industry has a similar Price/Forward Earnings ratio as HIMS.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 21.68, HIMS is valued quite expensively.
Industry RankSector Rank
PE 51.63
Fwd PE 45.29
HIMS Price Earnings VS Forward Price EarningsHIMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • HIMS's Enterprise Value to EBITDA ratio is in line with the industry average.
  • HIMS's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. HIMS is more expensive than 61.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 104.53
EV/EBITDA 34.33
HIMS Per share dataHIMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as HIMS's earnings are expected to grow with 33.46% in the coming years.
PEG (NY)3.69
PEG (5Y)N/A
EPS Next 2Y11.95%
EPS Next 3Y33.46%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HIMS Dividend Analysis

5.1 Amount

  • HIMS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HIMS Fundamentals: All Metrics, Ratios and Statistics

HIMS & HERS HEALTH INC

NYSE:HIMS (4/29/2026, 8:20:42 PM)

Premarket: 26.4 +0.07 (+0.27%)

26.33

-1.58 (-5.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength49.07
Industry Growth88.82
Earnings (Last)02-23
Earnings (Next)05-11
Inst Owners85.5%
Inst Owner Change-0.18%
Ins Owners5.53%
Ins Owner Change13.33%
Market Cap6.00B
Revenue(TTM)2.35B
Net Income(TTM)128.37M
Analysts70
Price Target25.34 (-3.76%)
Short Float %33.69%
Short Ratio1.79
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.8%
Min EPS beat(2)-43.53%
Max EPS beat(2)71.14%
EPS beat(4)3
Avg EPS beat(4)25.02%
Min EPS beat(4)-43.53%
Max EPS beat(4)71.14%
EPS beat(8)7
Avg EPS beat(8)139.72%
EPS beat(12)10
Avg EPS beat(12)110.2%
EPS beat(16)13
Avg EPS beat(16)84.74%
Revenue beat(2)1
Avg Revenue beat(2)-0.49%
Min Revenue beat(2)-2.18%
Max Revenue beat(2)1.2%
Revenue beat(4)2
Avg Revenue beat(4)0.65%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.24%
Revenue beat(12)8
Avg Revenue beat(12)1.06%
Revenue beat(16)12
Avg Revenue beat(16)2.47%
PT rev (1m)-15.55%
PT rev (3m)-43.02%
EPS NQ rev (1m)-31.43%
EPS NQ rev (3m)-84.69%
EPS NY rev (1m)6.46%
EPS NY rev (3m)-0.58%
Revenue NQ rev (1m)0.12%
Revenue NQ rev (3m)-5.39%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-0.42%
Valuation
Industry RankSector Rank
PE 51.63
Fwd PE 45.29
P/S 2.56
P/FCF 104.53
P/OCF 20.01
P/B 11.1
P/tB 90.27
EV/EBITDA 34.33
EPS(TTM)0.51
EY1.94%
EPS(NY)0.58
Fwd EY2.21%
FCF(TTM)0.25
FCFY0.96%
OCF(TTM)1.32
OCFY5%
SpS10.3
BVpS2.37
TBVpS0.29
PEG (NY)3.69
PEG (5Y)N/A
Graham Number5.21838 (-80.18%)
Profitability
Industry RankSector Rank
ROA 5.96%
ROE 23.73%
ROCE 6.95%
ROIC 5.49%
ROICexc 8.2%
ROICexgc 13.77%
OM 5.18%
PM (TTM) 5.47%
GM 73.83%
FCFM 2.45%
ROA(3y)6.14%
ROA(5y)-5.02%
ROE(3y)14.44%
ROE(5y)-1.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.63%
GM growth 5YN/A
F-Score5
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 16.94
Debt/EBITDA 5.52
Cap/Depr 445.11%
Cap/Sales 10.33%
Interest Coverage 250
Cash Conversion 170.27%
Profit Quality 44.73%
Current Ratio 1.9
Quick Ratio 1.7
Altman-Z 3.64
F-Score5
WACC8.86%
ROIC/WACC0.62
Cap/Depr(3y)344.08%
Cap/Depr(5y)250.41%
Cap/Sales(3y)5.65%
Cap/Sales(5y)4.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.27%
EPS Next Y14%
EPS Next 2Y11.95%
EPS Next 3Y33.46%
EPS Next 5Y50.73%
Revenue 1Y (TTM)59%
Revenue growth 3Y64.55%
Revenue growth 5YN/A
Sales Q2Q%28.41%
Revenue Next Year17.4%
Revenue Next 2Y18.31%
Revenue Next 3Y17.66%
Revenue Next 5Y13.74%
EBIT growth 1Y78.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year193.02%
EBIT Next 3Y66.22%
EBIT Next 5Y46.76%
FCF growth 1Y-71.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.48%
OCF growth 3YN/A
OCF growth 5YN/A

HIMS & HERS HEALTH INC / HIMS Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to HIMS.


What is the valuation status of HIMS & HERS HEALTH INC (HIMS) stock?

ChartMill assigns a valuation rating of 2 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.


How profitable is HIMS & HERS HEALTH INC (HIMS) stock?

HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 5 / 10.


How financially healthy is HIMS & HERS HEALTH INC?

The financial health rating of HIMS & HERS HEALTH INC (HIMS) is 3 / 10.


What is the expected EPS growth for HIMS & HERS HEALTH INC (HIMS) stock?

The Earnings per Share (EPS) of HIMS & HERS HEALTH INC (HIMS) is expected to grow by 14% in the next year.